/NICA.ST
NICA.ST Stock - Nanologica AB (publ)
Healthcare|BiotechnologySTO
$0.71+0.86%
+$0.01 (+0.86%) • Dec 23
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.5
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.78
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NICA.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.70 – $0.71
TARGET (TP)$0.81
STOP LOSS$0.65
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.01
52W High$2.50
52W Low$0.67
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $14.54M | $1.44M | $1.55M | $12.91M | $16.14M |
| Gross Profit | $4.29M | $-76,000 | $3.23M | $4.92M | $14.99M |
| Gross Margin | 29.5% | -5.3% | 208.0% | 38.1% | 92.9% |
| Operating Income | $-59,255,000 | $-69,963,000 | $-50,137,000 | $-39,031,000 | $-20,105,000 |
| Net Income | $-65,629,000 | $-75,157,000 | $-55,090,000 | $-50,132,000 | $-24,826,000 |
| Net Margin | -451.4% | -5208.4% | -3542.8% | -388.2% | -153.9% |
| EPS | $-1.32 | $-2.05 | $-1.81 | $-1.77 | $-1.03 |
Company Overview
Nanologica AB (publ), a nanotechnology company, develops nanoporous silica for applications in the life science industry. The company offers nanoporous silica particles for drug development and chromatography separation. It provides NLAB Silica, a technology platform for drug delivery; NLAB Spiro, an inhalation platform for pulmonary drug delivery; SVEA (U)HPLC analytical columns; and preparative chromatography. Nanologica AB (publ) was founded in 2004 and is based in Södertälje, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NICA.STBeat Rate
38%
Last 13 quarters
Avg Surprise
-24.2%
EPS vs Estimate
Beats / Misses
5/7
1 met exactly
Latest EPS
$-0.12
Q4 2025
EPS Surprise History
Q1 24
-5.7%
$-1.01vs$-0.96
Q2 24
No data
Q3 24
+16.7%
$-0.25vs$-0.30
Q4 24
-178.7%
$-0.54vs$-0.19
Q1 25
-90.0%
$-0.19vs$-0.10
Q2 25
No data
Q3 25
-39.3%
$-0.14vs$-0.10
Q4 25
+37.8%
$-0.12vs$-0.20
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Oct 23, 2025 | $-0.20 | $-0.12 | +37.8% | ✓ BEAT |
Q3 2025 | Jul 10, 2025 | $-0.10 | $-0.14 | -39.3% | ✗ MISS |
Q2 2025 | Apr 16, 2025 | — | $-0.12 | — | — |
Q1 2025 | Feb 14, 2025 | $-0.10 | $-0.19 | -90.0% | ✗ MISS |
Q4 2024 | Nov 8, 2024 | $-0.19 | $-0.54 | -178.7% | ✗ MISS |
Q3 2024 | Jul 5, 2024 | $-0.30 | $-0.25 | +16.7% | ✓ BEAT |
Q2 2024 | Apr 26, 2024 | — | $-0.51 | — | — |
Q1 2024 | Feb 2, 2024 | $-0.96 | $-1.01 | -5.7% | ✗ MISS |
Q4 2023 | Oct 27, 2023 | $-0.40 | $-0.32 | +20.0% | ✓ BEAT |
Q3 2023 | Jul 7, 2023 | $-0.40 | $-0.40 | 0.0% | = MET |
Q2 2023 | Apr 28, 2023 | — | $-0.37 | — | — |
Q1 2023 | Feb 10, 2023 | $-0.45 | $-0.43 | +4.8% | ✓ BEAT |
Q4 2022 | Nov 11, 2022 | $-0.46 | $-0.39 | +15.0% | ✓ BEAT |
Q3 2022 | Aug 19, 2022 | $-0.42 | $-0.48 | -14.3% | ✗ MISS |
Q2 2022 | Apr 29, 2022 | $-0.39 | $-0.57 | -46.2% | ✗ MISS |
Q1 2022 | Mar 9, 2022 | $-0.40 | $-0.54 | -35.1% | ✗ MISS |
Q4 2021 | Oct 30, 2021 | — | $-0.45 | — | — |
Q3 2021 | Jul 9, 2021 | — | $-0.33 | — | — |
Q2 2021 | Apr 24, 2021 | — | $-0.28 | — | — |
Q1 2021 | Feb 26, 2021 | — | $-0.15 | — | — |
Latest News
Loading news...
Frequently Asked Questions about NICA.ST
What is NICA.ST's current stock price?
Nanologica AB (publ) (NICA.ST) is currently trading at $0.71 per share. The stock has moved +0.86% today.
What is the analyst price target for NICA.ST?
No analyst price targets are currently available for this stock.
What sector is Nanologica AB (publ) in?
Nanologica AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is NICA.ST's market cap?
Nanologica AB (publ) has a market capitalization of $0.06 billion, making it a small-cap company.
Does NICA.ST pay dividends?
No, Nanologica AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACTI.ST
Active Biotech AB (publ)
$0.04
Mkt Cap: $0.1B
BIOSGN.ST
Biosergen AB
$42.60
Mkt Cap: $0.1B
BIOVIC-B.ST
Biovica International AB (publ)
$0.34
Mkt Cap: $0.1B
CMOTEC-B.ST
Scandinavian ChemoTech AB (publ)
$4.79
Mkt Cap: $0.1B
NXTCL.ST
NextCell Pharma AB
$0.70
Mkt Cap: $0.1B
PILA.ST
Pila Pharma AB (publ)
$2.20
Mkt Cap: $0.1B
SPAGO.ST
Spago Nanomedical AB (publ)
$0.10
Mkt Cap: $0.0B
SPRINT.ST
Sprint Bioscience AB (publ)
$1.45
Mkt Cap: $0.2B
VIVE.ST
Vivesto AB
$0.14
Mkt Cap: $0.1B
XBRANE.ST
Xbrane Biopharma AB (publ)
$10.88
Mkt Cap: $0.1B
Explore stocks similar to NICA.ST for comparison